Open access · CC-BY
via OpenAlex
Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
Aigli‐Ioanna Legaki, Ioannis I. Moustakas, Michalina Sikorska, Grigorios Papadopoulos, Rallia-Iliana Velliou, Antonios Chatzigeorgiou
Current Obesity Reports · 2022 · ▲ 105 citations
Abstract
PURPOSE OF THE REVIEW: Mitochondrial dysfunction(definition) has long been proposed to play a crucial role in the pathogenesis of a considerable number of disorders, such as neurodegeneration, cancer, cardiovascular, and metabolic disorders, including obesity-related insulin resistance and non-alcoholic fatty liver disease (NAFLD). Mitochondria are highly dynamic organelles that undergo functional and structural adaptations to meet the metabolic requirements of the cell. Alterations in nutrient availability or cellular energy needs can modify their formation through biogenesis and the opposite processes of fission and fusion, the fragmentation, and connection of mitochondrial network areas respectively. Herein, we review and discuss the current literature on the significance of mitochondrial adaptations in obesity and metabolic dysregulation, emphasizing on the role of hepatocyte mitochondrial flexibility in obesity and NAFLD. RECENT FINDINGS: Accumulating evidence suggests the involvement of mitochondrial morphology and bioenergetics dysregulations to the emergence of NAFLD and its progress to non-alcoholic steatohepatitis (NASH). Most relevant data suggests that changes in liver mitochondrial dynamics and bioenergetics hold a key role in the pathogenesis of NAFLD. During obesity and NAFLD, oxidative stress occurs due to the excessive production of ROS, leading to mitochondrial dysfunction. As a result, mitochondria become incompetent and uncoupled from respiratory chain activities, further promoting hepatic fat accumulation, while leading to liver inflammation, insulin resistance, and disease's deterioration. Elucidation of the mechanisms leading to dysfunctional mitochondrial activity of the hepatocytes during NAFLD is of predominant importance for the development of novel therapeutic approaches towards the treatment of this metabolic disorder.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s13679-022-00473-1
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Legaki, A., Moustakas, I.I., Sikorska, M., Papadopoulos, G., Velliou, R., & Chatzigeorgiou, A. (2022). Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease. <em>Current Obesity Reports</em>. https://doi.org/10.1007/s13679-022-00473-1
Vancouver
Legaki A, Moustakas II, Sikorska M, Papadopoulos G, Velliou R, Chatzigeorgiou A. Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease. Current Obesity Reports. 2022. doi:10.1007/s13679-022-00473-1.
BibTeX
@article{aigliioanna2022Hepato,
title = {Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease},
author = {Aigli‐Ioanna Legaki and Ioannis I. Moustakas and Michalina Sikorska and Grigorios Papadopoulos and Rallia-Iliana Velliou and Antonios Chatzigeorgiou},
journal = {Current Obesity Reports},
year = {2022},
doi = {10.1007/s13679-022-00473-1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
World Journal of Gastroenterology 2008
Open access · CC-BY
Nonalcoholic fatty liver disease and mitochondrial dysfunction
Frontiers in Aging Neuroscience 2021
Open access · CC-BY
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
Journal of Obesity & Metabolic Syndrome 2023
Open access · CC-BY
Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Biomedicines 2023
Open access · CC-BY
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Pharmaceuticals (Basel, Switzerland) 2026
Open access · OA
Lysine Acetylation as a Regulatory Mechanism in Cardiometabolic Disease: A Focus on Sirtuins.
Annals of Medicine 2017
Open access · OA